Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236100 · ClinicalTrials.gov registry record · NA
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
A NA study of Substance-Related Disorders and Adverse Childhood Experiences, sponsored by RTI International.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT06236100 is a NA study of Substance-Related Disorders and Adverse Childhood Experiences that is actively recruiting participants, run by RTI International. The registered enrollment target is 360 participants, below the 1,515-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06236100, a NA study of Substance-Related Disorders and Adverse Childhood Experiences, is actively recruiting participants, sponsored by RTI International.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and ACEs. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the Strengthening Families Program (SFP) + Family Advocate (FA) intervention on substance use, overdose, and ACEs in 18 communities compared with SFP-only in 18 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for Implementation Research (CFIR) to explore implementation barriers and facilitators; and (3) conduct a cost evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help disproportionately affected communities prevent substance use, overdose, and ACEs.
Conditions Studied
Interventions
- BEHAVIORAL Strengthening Families Program + Family Advocate
- BEHAVIORAL Strengthening Families Program
Study Locations (1)
New Jersey
- New Jersey Prevention Network - Tinton Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2027-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236100
The ClinicalTrials.gov registry entry for NCT06236100 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,515-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (76% lower). The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Strengthening Families Program + Family Advocate is the first listed.
NCT06236100 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06236100 about?
NCT06236100 is a clinical study titled "Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program". Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and A...
What is the current status of trial NCT06236100?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2023-11-29. Estimated completion is 2027-09-29.
What conditions does trial NCT06236100 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Adverse Childhood Experiences.
What interventions are being tested in trial NCT06236100?
The interventions under investigation include: Strengthening Families Program + Family Advocate (BEHAVIORAL), Strengthening Families Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06236100?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06236100 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Explore more on PlainTrial
Substance-Related Disorders
All registered trials for this condition
Adverse Childhood Experiences
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.